NB-PP_1170x120

direct and indirect remuneration fees

NACDS weighs in on burdens associated with DIR fees

ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid

Pharmacies feel the DIR fee pain

Pharmacies feel the DIR fee pain

Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at

Coalition trains fire on DIR fees under Medicare Part D

Coalition trains fire on DIR fees under Medicare Part D

ALEXANDRIA, Va. — A group 118 health care stakeholders, including chain drug retailers, have called on Congress to crack down on direct and indirect remuneration (DIR) fees in Medicare Part D. Mobilized by the National Community Pharmacists Association (NCPA), the broad coalition sent letters to the Senate and House of Representatives to voice their support

Congress urged to move on DIR fee legislation

Congress urged to move on DIR fee legislation

ALEXANDRIA, Va. — Chain drug retailers were among 118 health care stakeholders calling on Congress this week to crack down on direct and indirect remuneration fees in Medicare Part D. Marshaled by the National Community Pharmacists Association, the broad coalition — also including independent pharmacies, pharmacy trade groups, drug distributors, pharmacy buying groups, supermarket retailers,

Pharmacy stakeholders unite against DIR fees

Pharmacy stakeholders unite against DIR fees

ALEXANDRIA, Va. — A group of 99 pharmacy retailers, suppliers and organizations applauded House and Senate lawmakers for introducing legislation to clamp down on retroactive direct and indirect remuneration fees imposed by pharmacy benefit managers in Medicare Part D. The National Community Pharmacists Association said the pharmacy stakeholders on Monday wrote letters to the House

NCPA razor-focused on DIR fees issue

NCPA razor-focused on DIR fees issue

Persistence is paying off for the National Community Pharmacists Association in its advocacy for more transparency with DIR fees. In a posting in its “The Dose” blog this week, NCPA noted that it continues to build congressional support in getting the Centers for Medicare & Medicaid Services (CMS) to finalize its guidance on direct and